02616.HK
CStone Pharmaceuticals
HKSE · Healthcare · Biotechnology · CN
HKD 6.19
+0.16%Margins
Gross margin
42.7%
EBITDA margin
-93.3%
EBIT margin
-104.8%
Net margin
-109.6%
FCF margin
-84.8%
-50.9%
Return on equity
-32.0%
Return on assets
-38.1%
Return on invested capital
0.35x
Asset turnover
-HKD 593.1M
Cash from operations
HKD 1.31
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026